Bright Health Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2020 | $489 M | No. 4 | $250 million to $1 billion | equity | SEC | |
| Dec 2019 | $424 M | No. 3 | $250 million to $1 billion | equity | SEC | |
| Nov 2018 | $200 M | No. 2 | $50 to $250 million | equity | SEC | |
| Mar 2016 | $47 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Bright Health Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2020).
SEC Form D · Sep 2020
It delivers 1 product named in the sources below.
See Products and services
The industry group it chose in its notices: Health Insurance.
SEC Form D · Sep 2020
Products#
1 named by the sources below.
- health insurance
Wikidata · Wikidata: product or material produced (P1056)
Services#
No services of Bright Health Inc. are on record.
Investors#
21 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 15 Angels II LLC | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Bessemer Venture Partners Century Fund Institutional L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Bessemer Venture Partners Century Fund L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Bessemer Venture Partners IX Institutional L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Bessemer Venture Partners IX L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Deer IX & Co. L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Deer IX & Co. Ltd. | Company | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Deer X & Co. L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Deer X & Co. Ltd. | Company | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Jeffrey Folick | Person | not stated | not stated | Held Series A, B, C and D preferred stock, director (Form 3, 2021) | SEC Form 3 |
| Jeffrey R. Immelt | Person | not stated | not stated | Held Series D and E preferred stock, director (Form 3, 2021) | SEC Form 3 |
| Nea 15 GP, LLC | Other | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Nea 17 GP, LLC | Other | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2022) | SEC Form 3 |
| NEA 18 Venture Growth Equity, L.P. | Venture capital | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2022) | SEC Form 3 |
| Nea 18 Vge GP, LLC | Other | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2022) | SEC Form 3 |
| NEA Partners 15, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| NEA Partners 17, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2022) | SEC Form 3 |
| NEA Partners 18 VGE, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2022) | SEC Form 3 |
| New Enterprise Associates 15, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| New Enterprise Associates 17, L.P. | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2022) | SEC Form 3 |
| Tomas Valdivia | Person | not stated | not stated | Held Series A preferred stock (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 67 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Cathy Mike Smith | Executive officer | Sep 2020 |
| G. Mike Mikan | Executive officer | Sep 2020 |
| Keith Mike Nelsen | Executive officer | Sep 2020 |
| Robert Sheehy | Executive officer | Sep 2020 |
| Tomas Mike Valdivia | Executive officer | Sep 2020 |
| Mike Mikan | Executive officer | Dec 2019 |
| Kyle Rolfing | Executive officer | Nov 2018 |
| Robert J. Sheehy | Executive officer | Apr 2016 |
| Tomas J. Valdivia | Executive officer | Apr 2016 |
| Adair Mike Newhall | Director | Sep 2020 |
| Andy Mike Slavitt | Director | Sep 2020 |
| G. Mike Mikan | Director | Sep 2020 |
| Jeff Mike Folick | Director | Sep 2020 |
| Jeff Mike Immelt | Director | Sep 2020 |
| Kedrick Mike Adkins | Director | Sep 2020 |
| Mohamad Mike Makhzoumi | Director | Sep 2020 |
| Naomi Mike Allen | Director | Sep 2020 |
| Robert Sheehy | Director | Sep 2020 |
| Steve Mike Kraus | Director | Sep 2020 |
| Adair Newhall | Director | Dec 2019 |
| Andy Slavitt | Director | Dec 2019 |
| Jeff Folick | Director | Dec 2019 |
| Mike Mikan | Director | Dec 2019 |
| Mohamed Makhzoumi | Director | Dec 2019 |
| Steve Kraus | Director | Dec 2019 |
| Kyle Rolfing | Director | Nov 2018 |
| Mohamad Makhzoumi | Director | Nov 2018 |
| Mohamad J. Makhzoumi | Director | Apr 2016 |
| Robert J. Sheehy | Director | Apr 2016 |
| Stephen J. Kraus | Director | Apr 2016 |
About
American health insurance company.